Modulation of protein production and degradation as an integrated approach to rapid sterilization of drug sensitive and resistant MTB.

Ended Cooperative Agreement Awarded Last action

Award ID
U19AI142735
Recipient
Awarding agency
Obligated
$81,245,948

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date
Funding
  • $57,835,249.09 Federal
  • $23,410,699.00 Non-federal
Place of performance
New York, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment -$3 $0
Amendment $0 $0
Amendment $5,472,466 $5,472,466
Amendment $5,472,466 $0
Amendment $5,956,416 $0
Amendment $5,956,416 $5,956,416
Amendment $5,956,416 $5,956,416
Amendment $5,956,416 $0
Amendment $6,025,401 $0
Amendment $6,025,401 $6,025,401
Amendment $0 $0
Amendment $5,528,394 $0
Original award $5,485,460 $0
Show all 13

Quick answers

Who received award U19AI142735?

U19AI142735 was awarded to The Global Alliance For TB Drug Development Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on April 1, 2019.

How much is award U19AI142735 worth?

$81,245,948 has been obligated on U19AI142735: $57,835,249 in federal funding and $23,410,699 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award